Fernwood Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fernwood Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-800	Closed	-$96.3K	–	450
2024 Q1	$96.3K	Buy	+800	New	+$98K	0.03%	268
2020 Q1	–	Sell	-1,400	Closed	-$209K	–	158
2019 Q4	$209K	Buy	+1,400	New	+$191K	0.1%	147
2019 Q3	–	Sell	-1,605	Closed	-$229K	–	185
2019 Q2	$229K	Sell	1,605 -875	-35%	-$118K	0.13%	136
2019 Q1	$355K	Sell	2,480 -200	-7%	-$26.1K	0.19%	108
2018 Q4	$332K	Hold	2,680	–	–	0.21%	105
2018 Q3	$451K	Sell	2,680 -400	-13%	-$68.8K	0.24%	101
2018 Q2	$531K	Sell	3,080 -200	-6%	-$32.7K	0.29%	85
2018 Q1	$495K	Hold	3,280	–	–	0.28%	86
2017 Q4	$442K	Buy	3,280 +35	+1%	+$4.85K	0.24%	93
2017 Q3	$475K	Buy	3,245 +200	+7%	+$30.2K	0.3%	83
2017 Q2	$473K	Buy	+3,045	New	+$466K	0.34%	81

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Fernwood Investment Management's JAZZ Position: Q2 2024 in Review

Fernwood Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 800 shares — an estimated $96.3K sold.

Fernwood Investment Management first reported a position in JAZZ in Q2 2017 and held it in 11 quarters. The position peaked at $531K in Q2 2018. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

Fernwood Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Fernwood Investment Management sold 800 Jazz Pharmaceuticals shares in Q2 2024, an estimated $96.3K.
Fernwood Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2017 and held it in 11 quarters.
Fernwood Investment Management's Jazz Pharmaceuticals position peaked at $531K in Q2 2018.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.